Table 2 All treatments, deaths, and ocular preservations in survivors

Trilateral-onset n = 1

n = 1

RT and Systemic chemotherapy

1

1 (Pt 2)

0

(0%)

Bilateral-onset n = 38

n = 38

Enucleation and/or Local therapy alone

5

0

1 / 5

(25%)

Enucleation and/or Local therapy with RT

8

2 (Pt 3, Pt 6)

2 / 6

(33%)

Systemic chemotherapy

25

2 (Pt 5, Pt 1)

0 / 8^a

(0%)

with RT (and IAC)

10 (1)

2

2/ 15

(13%)

w/o RT (and IAC)

15 (5)

0

0

(0%)

4/38 (10.5%)

5/38

(13.2%)

Unilateral-onset n = 77

n = 77

Enucleation and/or Local therapy alone

52

0

0 / 52

(0%)

Enucleation and/or Local therapy with RT

2

0

0 / 2

(0%)

Systemic chemotherapy

23

1 (Pt 4)

0 / 4

(0%)

with RT

5

1

4 / 18

(22%)

w/o RT (and IAC)

18 (4)

0

0 / 52

(0%)

1/77 (1.3%)

4/77

(5.2%)